Junhe Li
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Ubiquitin and proteasome pathways
- Phytochemical compounds biological activities
Papers in
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 4
-
- Phytochemical compounds biological activities 5
- Ubiquitin and proteasome pathways 5
- RNA modifications and cancer 4
- Cancer-related gene regulation 3
- Co-authors
- Jianping Xiong (14 shared papers)Jun Deng (8 shared papers)Xiaojun Xiang (11 shared papers)Ling Zhang (3 shared papers)Jun Chen (8 shared papers)Shanshan Huang (9 shared papers)Zhiwang Song (3 shared papers)Lei Wan (1 shared paper)
- Journals
- Journal of Cellular and Molecular Medicine (3 papers)Biochemical and Biophysical Research Communications (2 papers)The Prostate (2 papers)Cancer Letters (2 papers)Gene (1 paper)
- Partner nations
- ChinaSouth KoreaPoland
In The Last Decade
Junhe Li
30 papers receiving 901 citations
Junhe Li's Hit Papers
Peers
Comparison fields: 5 of 69
- Cancer Research 301
- Molecular Biology 504
- Cell Biology 89
- Oncology 131
- Immunology 77
Countries citing papers authored by Junhe Li
This map shows the geographic impact of Junhe Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junhe Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junhe Li more than expected).
Fields of papers citing papers by Junhe Li
This network shows the impact of papers produced by Junhe Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junhe Li. The network helps show where Junhe Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Junhe Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 103 | |
| 2 | 2012 | 92 | |
| 3 | Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2024 | 80 |
| 4 | The role of Axl in drug resistance and epithelial-to-mesenchymal transition of non-small cell lung carcinoma. | 2014 | 73 |
| 5 | 2018 | 52 | |
| 6 | UCHL3 promotes pancreatic cancer progression and chemo-resistance through FOXM1 stabilization. | 2019 | 47 |
| 7 | 2020 | 40 | |
| 8 | 2020 | 38 | |
| 9 | 2017 | 36 | |
| 10 | 2022 | 34 | |
| 11 | 2022 | 32 | |
| 12 | 2021 | 32 | |
| 13 | 2020 | 27 | |
| 14 | 2018 | 23 | |
| 15 | 2020 | 21 | |
| 16 | 2016 | 21 | |
| 17 | 2021 | 18 | |
| 18 | 2020 | 18 | |
| 19 | 2018 | 16 | |
| 20 | 2020 | 15 |
About Junhe Li
Junhe Li is a scholar working on Cancer Research, Molecular Biology, Cell Biology, Biochemistry and Endocrinology, Diabetes and Metabolism, having authored 30 papers that have together received 905 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), Hippo pathway signaling and YAP/TAZ (5 papers), Phytochemical compounds biological activities (5 papers), Ubiquitin and proteasome pathways (5 papers), RNA modifications and cancer (4 papers), MicroRNA in disease regulation (4 papers), Cancer-related gene regulation (3 papers) and Traditional and Medicinal Uses of Annonaceae (2 papers). The work is most often cited by research in Cancer Research (301 citations), Molecular Biology (504 citations), Cell Biology (89 citations), Oncology (131 citations) and Immunology (77 citations). Junhe Li has collaborated with scholars based in China, South Korea and Poland. Frequent co-authors include Jianping Xiong, Jun Deng, Xiaojun Xiang, Ling Zhang, Jun Chen, Shanshan Huang, Zhiwang Song, Lei Wan, Fang Wu and Yangyang Yao. Their work appears in journals such as Journal of Cellular and Molecular Medicine, Biochemical and Biophysical Research Communications, The Prostate, Cancer Letters and Gene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.